Patent Assignment
Reel/Frame 067647/0303
Assignment of Assignor's Interest
Recorded: 2024-06-06
Pages: 18
Assignor
IDORSIA PHARMACEUTICALS LTD.
Executed: 2024-04-25
Assignee
VIATRIS ASIA PACIFIC PTE. LTD.
2 SHENTON WAY, #18-01, SGX CENTRE 1, SINGAPORE, 068804, SINGAPORE
Covered Properties
(23)
Pyrimidine Derivatives and Their Use as P2Y12 Receptor Antagonists
Pyridin-4-Yl Derivatives as Immunomodulating Agents
2-Aminocarbonyl-Pyridine Derivatives
2-Phenyl-6-Aminocarbonyl-Pyrimidine Derivatives and Their Use as P2Y12 Receptor
Phosphonic Acid Derivates and Their Use as P2Y12 Receptor Antagonists
Pyridin-2-Yl Derivatives as Immunomodulating Agents
Substituted 2-Phenyl-Pyridine Derivatives
2-Phenyl-4-Cyclopropyl-Pyrimidine Derivatives
6-(3-Aza-Bicyclo[3.1.0]Hex-3-Yl)-2-Phenyl-Pyrimidines
Thiazole Derivatives and Their Use as P2Y12 Receptor Antagonists
Pyridin-4-Yl Derivatives
2-Methoxy-Pyridin-4-Yl-Derivatives
Pyridin-4-Yl Derivatives
Crystalline Form of the Compound (S)-3-{4-[5-(2-Cyclopentyl-6-Methoxy-Pyridin-4-Yl)-[1,2,4]Oxadiazol-3-Yl]-2-Ethyl-6-Methyl-Phenoxy}-Propane-1,2-Diol
Crystalline Forms
Subcutaneous Administration of a P2Y12 Receptor Antagonist
Crystalline Form of the Compound (S)-3-{4-[5-(2-Cyclopentyl-6-Methoxy-Pyridin-4-Yl)-[1,2,4]Oxadiazol-3-Yl]-2-Ethyl-6-Methyl-Phenoxy}-Propane-1,2-Diol
Crystalline Forms
Crystalline Form of the Compound (S)-3-{4-[5-(2-Cyclopentyl-6-Methoxy-Pyridin-4-Yl)-[1,2,4]Oxadiazol-3-Yl]-2-Ethyl-6-Methyl-Phenoxy}-Propane-1,2-Diol
Crystalline Forms
Crystalline Form of the Compound (S)-3-{4-[5-(2-Cyclopentyl-6-Methoxy-Pyridin-4-Yl)-[1,2,4]Oxadiazol-3-Yl]-2-Ethyl-6-Methyl-Phenoxy}-Propane-1,2-Diol
Aqueous Pharmaceutical Composition Comprising a P2Y12 Receptor Antagonist
Application:
18/016,299 →
Publication:
US 2023/0255987
Process for the Synthesis of 4-((R)-2-{[6-((S)-3-Methoxy-Pyrrolidin-1-Yl)-2-Phenyl-Pyrimidine-4-Carbonyl]-Amino}-3-Phosphono-Propionyl)-Piperazine-1-Carboxylic Acid Butyl Ester
Application:
18/579,110 →
Publication:
US 2024/0317784
Related Assignments
(23)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Jan 23, 2008
From: CAROFF, EVA; FRETZ, HEINZ; HILPERT, KURT; HOUILLE, OLIVIER
To: ACTELION PHARMACEUTICALS, LTD.
Reel/Frame 020435/0883 →
Assignment of Assignor's Interest
Nov 8, 2010
From: CAROFF, EVA; HILPERT, KURT; MEYER, EMMANUEL
To: ACTELION PHARMACEUTICALS LTD
Reel/Frame 025330/0746 →
Assignment of Assignor's Interest
Nov 23, 2010
From: CAROFF, EVA; HILPERT, KURT; HUBLER, FRANCIS; MEYER, EMMANUEL
To: ACTELION PHARMACEUTICALS LTD.
Reel/Frame 025396/0005 →
Assignment of Assignor's Interest
Nov 22, 2011
From: CAROFF, EVA; HILPERT, KURT; MEYER, EMMANUEL
To: ACTELION PHARMACEUTICALS LTD.
Reel/Frame 027269/0090 →
Assignment of Assignor's Interest
Feb 9, 2012
From: BOLLI, MARTIN; LESCOP, CYRILLE; MATHYS, BORIS; MORRISON, KEITH
To: ACTELION PHARMACEUTICALS LTD.
Reel/Frame 027677/0559 →
Assignment of Assignor's Interest
Mar 12, 2012
From: CAROFF, EVA; HILPERT, KURT; HUBLER, FRANCIS; LEHMANN, DAVID
To: ACTELION PHARMACEUTICALS LTD.
Reel/Frame 027847/0139 →
Assignment of Assignor's Interest
Apr 26, 2012
From: BOLLI, MARTIN; LEHMANN, DAVID; MATHYS, BORIS; MUELLER, CLAUS
To: ACTELION PHARMACEUTICALS LTD
Reel/Frame 028109/0315 →
Assignment of Assignor's Interest
May 11, 2012
From: BOLLI, MARTING; LESCOP, CYRILLE; MATHYS, BORIS; MUELLER, CLAUS
To: ACTELION PHARMACEUTICALS LTD.
Reel/Frame 028196/0313 →
Assignment of Assignor's Interest
Jun 19, 2012
From: CAROFF, EVA; HILPERT, KURT; HUBLER, FRANCIS; MEYER, EMMANUEL
To: ACTELION PHARMACEUTICALS LTD.
Reel/Frame 028398/0773 →
Assignment of Assignor's Interest
Mar 7, 2013
From: CAROFF, EVA; HILPERT, KURT; HUBLER, FRANCIS; MEYER, EMMANUEL
To: ACTELION PHARMACEUTICALS LTD.
Reel/Frame 029942/0935 →
Assignment of Assignor's Interest
Jul 19, 2013
From: BOLLI, MARTIN; LESCOP, CYRILLE; MATHYS, BORIS; MORRISON, KEITH
To: ACTELION PHARMACEUTICALS LTD.
Reel/Frame 030840/0406 →
Assignment of Assignor's Interest
Sep 28, 2015
From: BOLLI, MARTIN; LESCOP, CYRILLE; NAYLER, OLIVER; STEINER, BEAT
To: ACTELION PHARMACEUTICALS LTD.
Reel/Frame 036672/0304 →
Assignment of Assignor's Interest
May 13, 2017
From: ACTELION PHARMACEUTICALS LTD
To: IDORSIA PHARMACEUTICALS LTD
Reel/Frame 042464/0407 →
Corrective Assignment to Correct the Assignee Address Previously Recorded at Reel: 042464 Frame: 0407. Assignor(S) Hereby Confirms the Assignment.
Jun 28, 2017
From: ACTELION PHARMACEUTICALS LTD
To: IDORSIA PHARMACEUTICALS LTD
Reel/Frame 043017/0022 →
Assignment of Assignor's Interest
Jan 22, 2018
From: LESCOP, CYRILLE
To: ACTELION PHARMACEUTICALS LTD
Reel/Frame 044691/0810 →
Assignment of Assignor's Interest
Jan 23, 2018
From: ACTELION PHARMACEUTICALS LTD
To: IDORSIA PHARMACEUTICALS LTD
Reel/Frame 044705/0234 →
Assignment of Assignor's Interest
Jan 9, 2020
From: ACTELION PHARMACEUTICALS LTD
To: IDORSIA PHARMACEUTICALS LTD
Reel/Frame 051471/0410 →
Assignment of Assignor's Interest
Jan 9, 2020
From: BAUMANN, MARTINE; KRAMBERG, MARKUS; REY, MARKUS; RIEDERER, MARKUS
To: ACTELION PHARMACEUTICALS LTD
Reel/Frame 051471/0520 →
Assignment of Assignor's Interest
Apr 28, 2020
From: ACTELION PHARMACEUTICALS LTD
To: IDORSIA PHARMACEUTICALS LTD
Reel/Frame 052509/0021 →
Assignment of Assignor's Interest
Apr 28, 2020
From: LEUENBERGER, DANIEL; REBER, STEFAN; VON RAUMER, MARKUS
To: ACTELION PHARMACEUTICALS LTD
Reel/Frame 052509/0001 →
Assignment of Assignor's Interest
Aug 26, 2020
From: DINGEMANSE, JASPER; KRAUSE, ANDREAS
To: ACTELION PHARMACEUTICALS LTD
Reel/Frame 053596/0769 →
Assignment of Assignor's Interest
Nov 3, 2020
From: ACTELION PHARMACEUTICALS LTD
To: IDORSIA PHARMACEUTICALS LTD
Reel/Frame 054249/0859 →
Corrective Assignment to Correct the List of Assignors Previously Recorded at Reel: 053596 Frame: 0769. Assignor(S) Hereby Confirms the Assignment.
Nov 3, 2020
From: DINGEMANSE, JASPER; KRAUSE, ANDREAS; LESCOP, CYRILLE
To: ACTELION PHARMACEUTICALS LTD
Reel/Frame 054330/0149 →